MSA
AVNS

Mason Street Advisors’s Avanos Medical AVNS Stock Holding History

Mason Street Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,546
Closed -$1.17M – 122
2020
Q4 		$1.17M Sell
25,546
-54
-0.2% -$2.25K 0.02% 861
2020
Q3 		$850K Sell
25,600
-571
-2% -$18.2K 0.02% 888
2020
Q2 		$769K Buy
26,171
+678
+3% +$19.6K 0.02% 928
2020
Q1 		$687K Hold
25,493
– – 0.02% 873
2019
Q4 		$859K Buy
25,493
+473
+2% +$17.1K 0.02% 942
2019
Q3 		$937K Sell
25,020
-301
-1% -$11.5K 0.02% 870
2019
Q2 		$1.1M Buy
25,321
+87
+0.3% +$3.72K 0.02% 816
2019
Q1 		$1.08M Buy
25,234
+391
+2% +$17.5K 0.02% 860
2018
Q4 		$1.11M Buy
24,843
+559
+2% +$29.3K 0.03% 764
2018
Q3 		$1.66M Buy
24,284
+170
+0.7% +$10.9K 0.03% 671
2018
Q2 		$1.38M Buy
24,114
+548
+2% +$29K 0.03% 753
2018
Q1 		$1.09M Buy
23,566
+513
+2% +$24.4K 0.02% 814
2017
Q4 		$1.06M Sell
23,053
-172
-0.7% -$7.91K 0.02% 827
2017
Q3 		$1.05M Buy
23,225
+427
+2% +$18.2K 0.02% 829
2017
Q2 		$896K Buy
22,798
+751
+3% +$28.4K 0.02% 852
2017
Q1 		$840K Buy
22,047
+263
+1% +$10.2K 0.02% 865
2016
Q4 		$806K Buy
21,784
+190
+0.9% +$6.79K 0.02% 863
2016
Q3 		$748K Buy
21,594
+311
+1% +$10.9K 0.02% 863
2016
Q2 		$692K Buy
21,283
+987
+5% +$30.2K 0.02% 855
2016
Q1 		$583K Buy
20,296
+772
+4% +$20.6K 0.02% 878
2015
Q4 		$652K Buy
19,524
+357
+2% +$11.1K 0.02% 854
2015
Q3 		$545K Buy
19,167
+305
+2% +$10.6K 0.02% 871
2015
Q2 		$764K Buy
18,862
+119
+0.6% +$5.34K 0.02% 825
2015
Q1 		$922K Sell
18,743
-107,428
-85% -$4.98M 0.03% 778
2014
Q4 		$5.74M Buy
+126,171
New +$4.96M 0.04% 500

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mason Street Advisors's AVNS Position: Q1 2021 in Review

Mason Street Advisors sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 25,546 shares — an estimated $1.17M sold.

Mason Street Advisors first reported a position in AVNS in Q4 2014 and held it in 25 quarters. The position peaked at $5.74M in Q4 2014. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

  • Mason Street Advisors reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 25,546 Avanos Medical shares in Q1 2021, an estimated $1.17M.
  • Mason Street Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 25 quarters.
  • Mason Street Advisors's Avanos Medical position peaked at $5.74M in Q4 2014.
  • 291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.